A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by Chemotherapy
Introduction: The prognosis of advanced gastric cancer patients, especially those with poor performance status (PS), is generally dismally poor. Patients with PS 3–4 are usually ineligible for participation in clinical studies and are managed with only best supportive care. Case Report: A 63-year-ol...
Main Authors: | Kohei Shitara, Daisuke Takahari |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2010-07-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/319169 |
Similar Items
-
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications
by: Kohei Shitara, et al.
Published: (2010-07-01) -
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
by: S B Dessai, et al.
Published: (2016-01-01) -
Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer
by: Hiroshi Matsumoto, et al.
Published: (2018-04-01) -
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
by: Masanori Tokunaga, et al.
Published: (2023-11-01) -
Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status
by: Yuka Aida, et al.
Published: (2019-08-01)